Adjuvant Effect of Triphala Darvyadi Ghan Vati in Diabetic Nephropathy.

Randomised Standard control clinical trial to evaluate an adjuvant effect of Triphala Darvyadi Ghan Vati in Madhumeha Upadrava with special referance to Diabetic Nephropathy. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058154

Enrollment

Registered

2023-09-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Signs & symptoms of Madhumeha (According to Charakacharya). 2. Signs & Symptoms of Madhumeha Upadrava related to Diabetic Nephropathy. 3. Known case of Non-Insulin Dependent Diabetes Mellitus (Type 2 DM). 4. Patients having HbA1c up to 12. 6. Patients with fasting blood sugar upto 250 mg/dl & postprandial blood sugar upto 350 mg/dl. 5. Patients taking oral hypoglycemic agents since 6 months. 6. Patients having Serum Creatinine level normal to 2.5 mg/dl.

Exclusion criteria

Exclusion criteria: 1. Patients with acute complications like hypoglycemic coma, ketoacidosis and related complications, history of complications, infections like gangrene. 2. Patients with known chronic diabetic complications such as end stage renal disease, patients receiving dialysis, cardiac complications, neuropathy. 3. Pregnant and lactating women. 4. Patients suffering from all major systemic diseases, IHD, TB, HIV, Carcinoma, uncontrolled HTN.

Design outcomes

Primary

Measure	Time frame
Evaluate the Effect of Triphala Darvyadi Ghan Vati as an Adjuvant with Standard of Care in Diabetic Nephropathy through RFT GFR, Urine Routine & Microscopic, ACR RatioTimepoint: 1st, 45th, 90th Day	—

Secondary

Measure	Time frame
Observe the Effect of Triphala Darvyadi Ghan Vati in BSL & HbA1cTimepoint: 1st, 45th, 90th Day	—

Countries

India

Contacts

Public ContactDr Pratiksha Dundappa Talawar

PDEAs College of Ayurved and Reaserch Centre Nigdi Pune

medhamaheshjoshi@gmail.com9881465798

Outcome results